Form 4: Charles River Laboratories CEO Acquires Stock Options
SEC Form 4 Filing
James C. Foster, Chairman, President, and CEO of Charles River Laboratories, reports acquisition of stock options.
Summary
- James C. Foster, Chairman, President, and CEO of Charles River Laboratories International, Inc., filed a Form 4 on June 4, 2024, reporting a transaction on May 31, 2024.
- The transaction involved the acquisition of 24,858 stock options with an exercise price of $208.44.
- These options vest in four equal installments beginning May 31, 2025, and expire on May 31, 2034.
- Foster also reported beneficial ownership of common stock held directly and indirectly through various trusts and by his spouse.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock option grants, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, common for publicly traded companies. It provides transparency regarding the holdings and transactions of company executives.
Stakeholder Impact
- The acquisition of stock options by the CEO could be viewed positively by shareholders as it aligns management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of earliest transaction: Acquisition of stock options. |
| 05/31/2025 | First vesting date for 6,214 stock options. |
| 05/31/2026 | Second vesting date for 6,215 stock options. |
| 05/31/2027 | Third vesting date for 6,214 stock options. |
| 05/31/2028 | Fourth vesting date for 6,215 stock options. |
| 05/31/2034 | Expiration date of the stock options. |
| 06/04/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.